The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease
Abstract
The incidence of end-stage renal disease (ESRD) has risen dramatically in the past decade, mainly due to the increasing prevalence of diabetes mellitus, and both impaired glucose tolerance and hypertension are important contributors to rising rates of ESRD. Obesity, especially the visceral type, is associated with peripheral resistance to insulin actions and hyperinsulinemia, which predisposes to development of diabetes. A common genetic predisposition to insulin resistance and hypertension and the coexistence of these two disorders predisposes to premature atherosclerosis. A constellation of metabolic and cardiovascular derangements, which also includes dyslipidemia, dysglycemia, endothelial dysfunction, fibrinolytic and inflammatory abnormalities, left ventricular hypertrophy, microalbuminuria, and increased oxidative stress, is referred to as the cardiometabolic syndrome. The components of this syndrome, individually and interdependently, substantially increase the risk of renal disease, cardiovascular disease (CVD) and mortality. Similar findings and cardiorenal risk factors can occur in subjects with android obesity without excess body weight.Recently, microalbuminuria has been gaining momentum as a component and marker for the cardiometabolic syndrome, in addition to being an early marker for progressive renal disease in patients with this syndrome or in those with diabetes. Furthermore, it is now established as an independent predictor of CVD and CVD mortality. This review examines the relationship between insulin resistance/hyperinsulinemia and hypertension in the context of cardiometabolic syndrome, progressive renal disease and accelerated CVD. The importance of microalbuminuria as an early marker for the cardiometabolic syndrome is also discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 3×
“K/AKT signaling pathways, and AngII inhibits this vasorelaxant effect of insulin/IGF-1 (7,9,12).”
BackgroundReaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Incidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
Mechanisms of Obesity-Associated Cardiovascular and Renal Disease
Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., & Dubbert, P. M. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200209000-00003 · Cited by 373
Ethnic Differences in Insulinemia and Sympathetic Tone as Links Between Obesity and Blood Pressure
Weyer, C., Pratley, R. E., Snitker, S., Spraul, M., Ravussin, E., & Tataranni, P. A. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.531 · Cited by 136
Cited by
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Wagner, R., Heni, M., Tabák, A. G., Machann, J., Schick, F., Randrianarisoa, E., Hrabě de Angelis, M., Birkenfeld, A. L., Stefan, N., Peter, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1116-9 · Cited by 415
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387
Role of Altered Renal Lipid Metabolism in the Development of Renal Injury Induced by a High-Fat Diet
Kume, S., Uzu, T., Araki, S.-I., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Kubota, N., Terauchi, Y., Kadowaki, T., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010089 · Cited by 278
Insulin resistance, insulin response, and obesity as indicators of metabolic risk
Ferrannini, E., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Nolan, J., Walker, M., Natali, A., & Beck-Nielsen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0334 · Cited by 193
Cheng, H.-T., Huang, J.-W., Chiang, C.-K., Yen, C.-J., Hung, K.-Y., & Wu, K.-D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2658 · Cited by 140
Metadata
- Authors
- El-Atat, F. A., Stas, S. N., McFarlane, S. I., & Sowers, J. R.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2004-11
- Volume
- 15
- Issue
- 11
- Pages
- 2816-2827
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2169900419
- Cited by
- 202
- References
- 11
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease. https://app.cochat.ai/papers/10.1097/01.asn.0000133698.80390.37
- The paper
- El-Atat, F. A., Stas, S. N., McFarlane, S. I., & Sowers, J. R. (2004). The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000133698.80390.37
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.